|
On surrogate end points in cancer research
|
|
12
|
6953
|
April 13, 2019
|
|
Statistics in the era of big data
|
|
3
|
3010
|
March 15, 2019
|
|
Competing risks analysis with multiple non-competing events
|
|
5
|
3455
|
March 8, 2019
|
|
Biostatisticians, have you ever rounded in the hospital with a clinical team or observed some days of work in a clinic?
|
|
13
|
3009
|
March 4, 2019
|
|
Misleading results from subgroup analysis combined with regression to the mean in crossover RCT’s
|
|
3
|
2950
|
March 4, 2019
|
|
Practical challenges of individualizing prognosis/risk
|
|
2
|
1875
|
March 3, 2019
|
|
Comparing healthcare cost between two arms of an RCT
|
|
3
|
3194
|
February 21, 2019
|
|
PFS estimation with alternative therapies prior to progression
|
|
5
|
1896
|
February 18, 2019
|
|
DSMB Blinding: Yes or No?
|
|
12
|
10461
|
January 26, 2019
|
|
A prescription for more precision in defining areas of expertise
|
|
5
|
1862
|
January 26, 2019
|
|
Time-dependent random effects in survival analysis
|
|
2
|
2531
|
January 9, 2019
|
|
Predicted probabilities for the entire population with nested case-control studies
|
|
6
|
4008
|
January 2, 2019
|
|
Inequality of Variances in an RCT
|
|
12
|
9068
|
December 27, 2018
|
|
What data can be recorded from patients who do not consent to be in a study?
|
|
7
|
5732
|
December 3, 2018
|
|
Time dependent variable with time dependent coefficient (at the same time)
|
|
4
|
4170
|
November 15, 2018
|
|
Charlson Comorbidity Index or Something Better?
|
|
2
|
3382
|
November 5, 2018
|
|
Clustering with categorical data
|
|
1
|
2164
|
October 30, 2018
|
|
Survival Analysis with Multiple Endpoints
|
|
2
|
4423
|
October 24, 2018
|
|
Questionnaire Validation with two different rating scales
|
|
1
|
1693
|
October 17, 2018
|
|
Principles and guidelines for applied statistics
|
|
29
|
17273
|
October 4, 2018
|
|
Power calculations for non-parametric data
|
|
3
|
10614
|
July 25, 2018
|